Similarly, the sorafenib-treated HCC cells with overexpression of CREB3L4 showed significant increase in cell proliferation and colony formation compared with the mock-Sorafenib or shNC-Sorafenib group. This evidence concerns the gene CREB3L4 and hepatocellular carcinoma.